Casimir Blonski

Antitrypanosomal alkaloids from Polyalthia suaveolens (Annonaceae): Their effects on three selected glycolytic enzymes of Trypanosoma brucei

In continuation of our study on medicinal plants of Cameroon, stem barks of Polyalthia suaveolens were phytochemically studied. This investigation yielded a new indolosesquiterpene alkaloid, named polysin (1) and four hitherto known alkaloids (2-5). Polysin (1) appeared as a competitive reversible inhibitor (K(i)=10 microM) of phosphofructo kinase (PFK) of Trypanosoma brucei with respect to fructose-6-phosphate (K(i)/K(M)=0.05) and could be used in the design of new trypanocidal drugs. The other isolated compounds (2-5) also exhibited interesting inhibitory effects on selected glycolytic enzymes (PFK, glyceraldehyde-3-phosphate dehydrogenase and aldolase).

Glycolysis and proteases as targets for the design of new anti-trypanosome drugs.

Glycolysis is considered as a promising target for new drugs against parasitic trypanosomatid protozoa, because this pathway plays an essential role in their ATP supply. Trypanosomatid glycolysis is unique in that it is compartmentalised, and many of its enzymes display specific structural and kinetic features. Structure- and catalytic mechanism-based approaches are applied to design compounds that inhibit the glycolytic enzymes of the parasites without affecting the corresponding proteins of the human host. For some trypanosomatid enzymes, potent and selective inhibitors have already been developed that affect only the growth of cultured trypanosomatids, and not mammalian cells. Examples are developed concerning all enzymes in the hexoses part with also others concerning glyceraldehyde-phosphate dehydrogenase and pyruvate-kinase for the trioses part. Concerning cysteine protease inhibitor development, a great number of irreversible alkylating agents have shown their efficacy towards the active site cysteine of parasite proteases. This includes fluoromethylketones, epoxides, diazomethylketones, vinylsulfones to mention a few. These functional groups are activated electrophiles that react with the nucleophilic cysteine of the active site and are generally quite selective for cysteine versus serine. They are thought to be also reactive to numerous other nucleophiles in the body, especially other thiols. This potentially hampering property seems not to be detrimental for two reasons: first a recent report has shown that cysteine protease inhibitors containing a vinylsulfone electrophile are unreactive towards thiols such as glutathione and can be considered to be inert in the absence of catalytic machinery. Secondly, irreversible inhibitors are shown to be less toxic than presumed in the parasite treatment, owing to some bioselectivity displayed by the parasite itself.

Spermidinyl-CoA-based HAT inhibitors block DNA repair and provide cancer-specific chemo- and radiosensitization

Acetyl group turnover on specific lysine ε-amino groups of the core chromosomal histones regulates DNA accessibility function, and the acetylating and deacetylating enzymes that govern the turnover provide important targets for the development of anti-cancer drugs. Histone deacetylase (HDAC) inhibitors have been developed and evaluated extensively in clinical trials, while the development of inhibitors of histone acetyltransferase (HAT) has proceeded more slowly. Here we have examined the cellular effects of an S-substituted coenzyme A (CoA) inhibitor of histone acetylation, consisting of spermidine (Spd) linked to the S-terminus of CoA through a thioglycolic acid linkage (adduct abbreviated as Spd-CoA), as well as the effects of a truncated Spd-CoA derivative lacking the negatively charged portion of the CoA moiety. While exposure of cancer cells to Spd-CoA has little effect on cell viability, it causes a rapid inhibition of histone acetylation that correlates with a transient arrest of DNA synthesis, a transient delay in S-phase progression, and an inhibition of nucleotide excision repair and DNA double strand break repair. These effects correlate with increased cellular sensitivity to the DNA-targeted chemotherapeutic drugs, cisplatin (Platinol™) and 5-Fluorouracil, to the DNA damaging drug, camptothecin, and to UV-C irradiation. The sensitization effects of Spd-CoA are not observed in normal cells due to a barrier to uptake. The truncated Spd-CoA derivative displays similar but enhanced chemosensitization effects, suggesting that further modifications of the Spd-CoA structure could further improve potency. The results demonstrate that Spd-CoA and its truncated version are efficiently and selectively internalized into cancer cells, and suggest that the resulting inhibition of acetylation-dependent DNA repair enhances cellular sensitivity to DNA damage. These and related inhibitors of histone acetylation could therefore constitute a novel class of potent therapy sensitizers applicable to a broad range of conventional cancer treatments.

Inhibition of the Glycolytic-enzymes in the Trypanosome - An Approach in the Development of New Leads in the Therapy of Parasitic Diseases

Glycolysis in the trypanosome represents an important target for the development of new therapeutic agents due to the fact that this metabolism is essential for the parasite, glucose being its sole source of energy. In addition, different features of this metabolism and those associated with glycolytic enzymes offer opportunities for the development of efficient and selective compounds. Examples are given in this work of inhibitors directed to the enzymes aldolase and glyceraldehyde-phosphate-dehydrogenase and also of molecules acting specifically on the clusters of basic amino-acids present at the surfaces of the glycolytic enzymes in the parasite.

An improved chemical and enzymatic synthesis of new fructose derivatives for import studies by the glucose transporter in parasites

Abstract This paper presents the chemoenzymatic synthesis of D-fructose analogues substituted at position C6. These compounds are the unique products of rabbit muscle aldolase catalyzed aldolisation of D-glyceraldehyde analogues (obtained by stereospecific chemical synthesis) with DHAP, followed by a dephosphorylation step with acid phosphatase.

Structural flexibility in Trypanosoma brucei enolase revealed by X-ray crystallography and molecular dynamics.

Enolase is a validated drug target in Trypanosoma brucei. To better characterize its properties and guide drug design efforts, we have determined six new crystal structures of the enzyme, in various ligation states and conformations, and have carried out complementary molecular dynamics simulations. The results show a striking structural diversity of loops near the catalytic site, for which variation can be interpreted as distinct modes of conformational variability that are explored during the molecular dynamics simulations. Our results show that sulfate may, unexpectedly, induce full closure of catalytic site loops whereas, conversely, binding of inhibitor phosphonoacetohydroxamate may leave open a tunnel from the catalytic site to protein surface offering possibilities for drug development. We also present the first complex of enolase with a novel inhibitor 2‐fluoro‐2‐phosphonoacetohydroxamate. The molecular dynamics results further encourage efforts to design irreversible species‐specific inhibitors: they reveal that a parasite enzyme‐specific lysine may approach the catalytic site more closely than crystal structures suggest and also cast light on the issue of accessibility of parasite enzyme‐specific cysteines to chemically modifying reagents. One of the new sulfate structures contains a novel metal‐binding site IV within the catalytic site cleft.

Synthesis of phosphono analogues of dihydroxyacetone phosphate and glyceraldehyde 3-phosphate

The present paper describes the synthetic routes of six phosphono analogues of dihydroxyacetone phosphate and five phosphono analogues of glyceraldehyde 3-phosphate through alpha-, beta- and gamma-hydroxyphosphonate esters precursors containing a protected carbonyl group. In some situations, depending on the sequence used for the deprotection of the phosphonate and carbonyl groups, the aldol/ketol rearrangement allowed the synthesis of either dihydroxyacetone phosphate or glyceraldehyde 3-phosphate analogues from the same precursors. All these analogues are of interest both as active-site probes and as potential substrates for glycolytic enzymes such as fructose 1,6-diphosphate aldolases (EC 4.1.2.13).

1,1-Bis-(4-methoxyphenyl)-1′-pyrenyl methyl (bmpm): a new fluorescent 5′ protecting group for the purification of unmodified and modified oligonucleotides

Abstract By replacing the phenyl by a pyrenyl in the dimethoxytrityl (DMTr) group commonly used for 5′-protection in oligonucleotide synthesis, we have obtained a fluorescent acid-labile protecting group which exhibits similar chemical properties to those of DMTr. Here we demonstrate the usefulness of the new protecting group in the purification of both charged and neutral DNA fragments.

BISMUTH(III) TRIFLATE: A SAFE AND EASILY HANDLED PRECURSOR FOR TRIFLIC ACID: APPLICATION TO THE ESTERIFICATION REACTION

A series of carboxylic acids were converted into their corresponding methyl esters using bismuth(III) triflate as a catalyst in methanol. Good to excellent yields were obtained for different aliphatic or aromatic starting materials. In the reaction, bismuth triflate acts as a precursor that, upon hydrolysis, liberates sufficient triflic acid to catalyze the esterification.

Chemical and enzymatic synthesis of fructose analogues as probes for import studies by the hexose transporter in parasites

Various D-fructose analogues modified at C-1 or C-6 positions were synthesized from D-glucose by taking advantage of the Amadori rearrangement or using the aldol condensation between dihydroxyacetone phosphate and appropriate aldehyde catalyzed by fructose 1,6-diphosphate aldolase from rabbit muscle. The affinities of the analogues for the glucose transporter expressed in the mammalian form of Trypanosoma brucei were determined by inhibition of radiolabelled 2-deoxy-D-glucose (2-DOG) transport using zero-trans kinetic analysis. Interestingly, the analogues bearing an aromatic group (i.e. a fluorescence marker) at C-1 or C-6 positions present comparable apparent affinities to D-fructose for the transporter. This result could find applications for hexose transport studies and also provides criteria for the design of glucose import inhibitors.